Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Risk Factors
Recommendations for hormone replacement therapy should not increase cancer risk
December 8th, 2005
Current recommendations for hormone replacement therapy should not increase ovarian cancer risk. According to scientists writing in the American Journal of Obstetrics and Gynecology, "The objective of [our] study was to determine if use of menopausal hormones was associated with ovarian cancer and if risk varied by type of hormone used." They explained, Data from a population-based, case-control study of ovarian cancer in North Carolina (364 cases, 370 controls, all postmenopausal) were analyzed to evaluate the relationship between menopausal hormones and ovarian cancer. Logistic regression analyses were used to calculate odds ratios (OR) and...
Source: Women's Health Weekly (2005-12-08)
|
